Pacific Biosciences Of California | PACB - Cost Of Sales


Pacific Biosciences Of California reported $26.97M in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Bruker USD 528M 46.9M Dec/2025
Danaher USD 2.87B 342M Dec/2025
General Electric Aerospace USD 8.92B 654M Dec/2025
Illumina USD 400M 49M Dec/2025
Myriad Genetics USD 61.9M 600K Sep/2025
Pacific Biosciences Of California USD 26.97M 5.12M Sep/2024
Quidel USD 448.8M 1.21B Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Standard Biotools USD 10.07M 1.06M Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Waters USD 374.94M 47.13M Dec/2025